Your browser doesn't support javascript.
loading
Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world study.
Brownlee, Wallace J; Haghikia, Aiden; Hayward, Brooke; Waser, Nathalie; Kayaniyil, Sheena; Khan, Zaeem; Duncan, Julie; Millar, Stefanie; Harty, Gerard T.
Afiliação
  • Brownlee WJ; Queen Square MS Centre, University College London Institute of Neurology and National Institute for Health and Care Research (NIHR) University College London Hospitals Biomedical Research Centre, London, UK.
  • Haghikia A; Ruhr-University Bochum & St. Josef-Hospital, Bochum, Germany.
  • Hayward B; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Waser N; ICON plc, 3455 North Service Rd, Burlington, Ontario L7N 3G2, Canada.
  • Kayaniyil S; ICON plc, 3455 North Service Rd, Burlington, Ontario L7N 3G2, Canada.
  • Khan Z; ICON plc, 3455 North Service Rd, Burlington, Ontario L7N 3G2, Canada.
  • Duncan J; ICON plc, Marlow, United Kingdom.
  • Millar S; ICON plc, Blue Bell, PA, USA.
  • Harty GT; Merck Healthcare KGaA, Darmstadt, Germany. Electronic address: gerard.harty@merckgroup.com.
Mult Scler Relat Disord ; 76: 104791, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37343465
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article